Argenx
ARGX
#627
Rank
C$43.93 B
Marketcap
$724.79
Share price
1.00%
Change (1 day)
3.02%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : C$6.50 B

According to Argenx 's latest financial reports the company's total assets are C$6.50 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2022-12-31C$4.25 B17.9%
2021-12-31C$3.60 B1.52%
2020-12-31C$3.55 B51.6%
2019-12-31C$2.34 B126.67%
2018-12-31C$1.03 B54.05%
2017-12-31C$0.67 B326.9%
2016-12-31C$0.15 B106.41%
2015-12-31C$76.18 M-24.16%
2014-12-31C$0.10 B97.88%
2013-12-31C$50.76 M68.07%
2012-12-31C$30.2 M-28.41%
2011-12-31C$42.19 M159.11%
2010-12-31C$16.28 M